Aurora Cannabis (ACB) Exchange Rate Effect (2017 - 2025)
Aurora Cannabis (ACB) posted quarterly Exchange Rate Effect of -$89000.0 for Q4 2025, down 103.33% year-on-year from $2.7 million in Q4 2024, and down 105.19% on a QoQ basis from $1.7 million in Q1 2025.
Aurora Cannabis (ACB) Exchange Rate Effect (2017 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has reported Exchange Rate Effect for 9 consecutive years, with -$89000.0 the latest figure, recorded in Q4 2025.
- Quarterly Exchange Rate Effect fell 103.33% year-over-year to -$89000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$94935.0 (up 88.06% YoY) and the FY2026 annual result came in at $2.3 million, up 1091.85% from the prior year.
- Exchange Rate Effect declined to -$89000.0 in Q4 2025 per ACB's latest filing, from $1.7 million in the prior quarter.
- Over the last five years, Exchange Rate Effect for ACB reached as high as $20.3 million in Q3 2022 and fell as low as -$21.3 million in Q2 2021.
- A 5-year average of $1.9 million and a median of $463475.1 in 2024 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2021 — Exchange Rate Effect jumped 562.97% — and 2022, when it slumped 1315.71%.
- Year by year, Exchange Rate Effect stood at -$6.7 million in 2021, then soared by 367.53% to $18.0 million in 2022, then sank by 105.43% to -$976197.7 in 2023, then jumped by 374.11% to $2.7 million in 2024, then tumbled by 103.33% to -$89000.0 in 2025.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$89000.0, $1.7 million, and $2.7 million for Q4 2025, Q1 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -89,000.00 |
| Dec 31, 2025 | -89,000.00 |
| Mar 31, 2025 | 1.72 Mn |
| Mar 31, 2025 | 1.72 Mn |
| Dec 31, 2024 | 2.68 Mn |
| Dec 31, 2024 | 2.68 Mn |
| Sep 30, 2024 | -4.40 Mn |
| Sep 30, 2024 | -4.40 Mn |
| Jun 30, 2024 | 46,061.85 |
| Jun 30, 2024 | 46,061.85 |
| Mar 31, 2024 | 880,888.38 |
| Mar 31, 2024 | 880,888.38 |
| Dec 31, 2023 | -976,197.72 |
| Dec 31, 2023 | -976,197.72 |
| Sep 30, 2023 | 1.63 Mn |
| Sep 30, 2023 | 1.63 Mn |
| Dec 31, 2022 | 17.98 Mn |
| Dec 31, 2022 | 17.98 Mn |
| Sep 30, 2022 | 20.28 Mn |
| Sep 30, 2022 | 20.28 Mn |